CARM Carisma Therapeutics Inc Year-over-year net earnings per share growth for the last 12 months

carismatx.com - graphic logo of issuer CARM

Carisma Therapeutics' business is vulnerable to Asian supply chain disruptions and patent conflicts. The quarterly EPS history clearly demonstrates the profit recovery trend, while the 12.80 metric confirms current yield levels. The issuer is optimizing costs through production outsourcing and the implementation of laboratory robotics for high-precision molecular analysis.

carismatx.com (CARM) Year-over-year earnings per share growth for the last 12 months: for the period 04/28/2023 - 10/25/2025

Analytical breakdowns and data insights for company carismatx.com (CARM)

- market value and analyst target forecast:
- market capitalization data:
Initial company analysis:Carisma Therapeutics
Flagship merchandise of Carisma Therapeutics

This indicator measures the percentage change in earnings per share compared to the same period last year, identifying the rate of capital scaling independently of market value. By analyzing quarterly earnings per share dynamics, an investor assesses the effectiveness of Carisma Therapeutics (CARM) strategic alliances with Moderna and Merck, where synergy in CAR-M therapy development directly impacts financial stability.

Who Carisma Therapeutics competes with

argenx BVBA (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech SE|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth admabiologics.com|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics Inc (PTGX)|Immunovant - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (kiniksa.com)|Grifols Group (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Adaptive Biotechnologies Inc. - Quarterly EPS earnings growth|Celldex Therapeutics (CLDX) - Year-over-year net earnings per share growth for the last 12 months|AUPH (auriniapharma.com) - Year-over-year net earnings per share growth for the last 12 months|BCRX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Vera Pharma|Quarterly EPS earnings growth Dianthus Corp|Year-over-year earnings per share growth for the last twelve months Pharvaris N.V. (PHVS)|ABCL - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Tourmaline Bio Inc TRML|Year-over-year net earnings per share change for the last twelve months Precigen (PGEN)|Pharming Corp - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months NKTR (Nektar Therapeutics)|upstreambio.com (UPB) - Year-over-year earnings per share growth for the last twelve months|ZBIO (Zenas Biopharma Inc) - Year-over-year earnings per share growth for the last twelve months|IMNM (Immunome Bio) - Quarterly EPS earnings growth|GOSS: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KALV (KalVista Pharmaceuticals Inc)|SEPN (Septerna Corp) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PVLA (Pieris Corp)|SVRA - Year-over-year net earnings per share growth for the last 12 months|RIGL - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months ANAB (AnaptysBio)|ATXS: Quarterly EPS earnings growth|ENGN - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RAPT|JBIO: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Aclaris Therapeutics (ACRS)|KYTX: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth TLSA (Tiziana Life Sciences, Ltd.)|Year-over-year net earnings per share change for the last twelve months Cabaletta Bio Inc (CABA)|ventyxbio.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months theratech.com|AVTX: Quarterly EPS earnings growth|ELDN: Year-over-year earnings per share growth rate for the last twelve months|AGEN (Agenus, Inc) - Quarterly EPS earnings growth|Climb Bio, Inc. - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Zura Bio (ZURA)|ATYR - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Adagene ADAG|Year-over-year earnings per one share growth for the last 12 months IMA|STTK: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months EQ (equilliumbio.com)|Connect Biopharma Holdings Limited (CNTB) - Year-over-year earnings per share growth for the last twelve months|Immunic, Inc. (IMUX) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months ATRA|IFRX: Year-over-year earnings per one share growth for the last 12 months|X4 Pharmaceuticals Inc. (XFOR) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months Adicet ACET|Quarterly EPS earnings growth CELU (Celularity Inc)|Quarterly EPS earnings growth INmune Bio INMB|Barinthus Biotherapeutics plc - Quarterly EPS earnings growth|Kezar Life Sciences, Inc. (KZR) - Year-over-year net earnings per share growth for the last 12 months|SAB Biotherapeutics, Inc (SABS) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Akari Therapeutics plc|Year-over-year earnings per share growth for the last twelve months enlivex.com|Earnings per share growth in annualized terms for the last twelve months q32bio.com QTTB|Year-over-year earnings per share growth for the last twelve months GeoVax Labs (GOVX)|EDSA (Edesa Biotech) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months ibioinc.com IBIO|Year-over-year earnings per one share growth for the last 12 months XTLB|BOLT: Year-over-year net earnings per share growth for the last 12 months|HCW Biologics (HCWB) - Year-over-year net earnings per share growth for the last 12 months|Aptevo (APVO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months AIM ImmunoTech|Year-over-year net earnings per share growth for the last 12 months ADTX|GRI Bio Corporation (GRI) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months XRTX (XORTX Therapeutics Inc.)|Vyome Holdings Inc - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Revelation Biosciences Inc REVB|INDP - Year-over-year net earnings per share growth for the last 12 months|SCNI: Year-over-year net earnings per share growth for the last 12 months|CALI: Year-over-year earnings per share growth for the last twelve months|AFMD: Quarterly EPS earnings growth|Allakos Inc - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months HOOKIPA Pharma, Inc.|IGM Biosciences, Inc. (IGMS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months iteostherapeutics.com (ITOS)|OCEA - Earnings per share growth in annualized terms for the last twelve months|TC BioPharm (Holdings) PLC - Year-over-year net earnings per share growth for the last 12 months|THRD: Year-over-year earnings per share growth for the last 12 months